Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK CLAUS RAALSKOV ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   5.9% 6.0% 3.0% 3.6% 5.4% 2.8% 11.8% 11.8%   Credit score (0-100)   41 40 57 50 41 58 20 20   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   31 21 24 81 22 40 40 40   Gross profit   -105 -185 889 -22.4 -19.7 -110 0.0 0.0   EBITDA   -1,167 -1,194 116 -1,221 -1,399 -1,160 0.0 0.0   EBIT   -1,248 -1,286 47.3 -1,244 -1,419 -1,179 0.0 0.0   Pre-tax profit (PTP)   287.5 160.4 1,557.7 -19.2 -117.7 300.2 0.0 0.0   Net earnings   224.0 110.0 1,273.0 -26.3 -129.7 299.9 0.0 0.0   Pre-tax profit without non-rec. items   288 160 1,558 -19.2 -118 300 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   155 77.9 47.3 97.2 63.7 44.8 0.0 0.0   Shareholders equity total   349 405 1,623 1,522 1,335 1,576 551 551   Interest-bearing liabilities   898 958 137 694 701 648 0.0 0.0   Balance sheet total (assets)   1,423 1,500 2,139 2,389 2,178 2,359 551 551   Net Debt   898 958 -550 -12.5 311 263 -551 -551     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   31 21 24 81 22 40 40 40   Net sales growth   -61.3% -30.6% 12.5% 236.4% -72.8% 82.9% 0.0% 0.0%   Gross profit   -105 -185 889 -22.4 -19.7 -110 0.0 0.0   Gross profit growth   2.7% -77.1% 0.0% 0.0% 11.9% -456.9% 0.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,423 1,500 2,139 2,389 2,178 2,359 551 551   Balance sheet change%   17.7% 5.4% 42.6% 11.7% -8.8% 8.3% -76.7% 0.0%   Added value   -1,166.8 -1,193.5 116.4 -1,220.8 -1,395.9 -1,160.4 0.0 0.0   Added value %   -3,778.5% -5,570.7% 482.9% -1,505.7% -6,332.7% -2,878.2% 0.0% 0.0%   Investments   -48 -233 -164 27 -53 -38 -45 0   Net sales trend   -2.0 -3.0 1.0 2.0 -1.0 1.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -3,778.5% -5,570.7% 482.9% -1,505.7% -6,347.3% -2,878.2% 0.0% 0.0%   EBIT %   -4,041.7% -6,004.0% 196.4% -1,533.8% -6,436.1% -2,925.1% 0.0% 0.0%   EBIT to gross profit (%)   1,192.9% 694.4% 5.3% 5,546.7% 7,185.9% 1,072.5% 0.0% 0.0%   Net Earnings %   725.2% 513.6% 5,282.0% -32.4% -588.2% 744.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   988.4% 947.0% 5,568.5% -4.3% -499.4% 790.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   931.1% 748.6% 6,463.5% -23.7% -534.0% 744.8% 0.0% 0.0%   ROA %   30.6% 18.6% 90.4% 7.8% 6.0% 16.9% 0.0% 0.0%   ROI %   35.0% 20.8% 105.4% 8.9% 6.4% 18.0% 0.0% 0.0%   ROE %   94.4% 29.2% 125.5% -1.7% -9.1% 20.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   24.5% 27.0% 75.9% 63.7% 61.3% 66.8% 100.0% 100.0%   Relative indebtedness %   3,478.2% 5,110.6% 2,143.4% 1,069.8% 3,821.5% 1,939.4% 0.0% 0.0%   Relative net indebtedness %   3,476.4% 5,110.6% -705.5% 198.4% 2,052.0% 986.6% -1,366.2% -1,366.2%   Net int. bear. debt to EBITDA, %   -76.9% -80.3% -472.6% 1.0% -22.2% -22.7% 0.0% 0.0%   Gearing %   257.3% 236.6% 8.4% 45.6% 52.5% 41.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.6% 12.0% 16.0% 47.3% 36.4% 12.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 1.2 3.6 2.2 2.0 2.2 0.0 0.0   Current Ratio   0.1 1.2 3.6 2.2 2.0 2.2 0.0 0.0   Cash and cash equivalent   0.6 0.0 686.6 706.6 390.1 384.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   306.5% 5,406.7% 7,679.6% 2,391.2% 7,522.2% 4,305.2% 1,366.2% 1,366.2%   Net working capital   -979.4 196.9 946.1 364.8 426.0 574.3 0.0 0.0   Net working capital %   -3,171.7% 918.9% 3,925.6% 450.0% 1,932.6% 1,424.6% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 40 0 0   Added value / employee   0 0 0 0 0 -1,160 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -1,160 0 0   EBIT / employee   0 0 0 0 0 -1,179 0 0   Net earnings / employee   0 0 0 0 0 300 0 0